Global Gram-Negative Bacterial Infection Therapeutics Market Report, History and Forecast 2015-2026, Breakdown Data by Companies, Key Regions, Types and Application
SKU ID : QYR-16979059 | Publishing Date : 15-Dec-2020 | No. of pages : 117
Detailed TOC of Global Gram-Negative Bacterial Infection Therapeutics Market Report, History and Forecast 2015-2026, Breakdown Data by Companies, Key Regions, Types and Application
1 Market Overview of Gram-Negative Bacterial Infection Therapeutics1.1 Gram-Negative Bacterial Infection Therapeutics Market Overview
1.1.1 Gram-Negative Bacterial Infection Therapeutics Product Scope
1.1.2 Market Status and Outlook
1.2 Global Gram-Negative Bacterial Infection Therapeutics Market Size Overview by Region 2015 VS 2020 VS 2026
1.3 Global Gram-Negative Bacterial Infection Therapeutics Market Size by Region (2015-2026)
1.4 Global Gram-Negative Bacterial Infection Therapeutics Historic Market Size by Region (2015-2020)
1.5 Global Gram-Negative Bacterial Infection Therapeutics Market Size Forecast by Region (2021-2026)
1.6 Key Regions, Gram-Negative Bacterial Infection Therapeutics Market Size YoY Growth (2015-2026)
1.6.1 North America Gram-Negative Bacterial Infection Therapeutics Market Size YoY Growth (2015-2026)
1.6.2 Europe Gram-Negative Bacterial Infection Therapeutics Market Size YoY Growth (2015-2026)
1.6.3 China Gram-Negative Bacterial Infection Therapeutics Market Size YoY Growth (2015-2026)
1.6.4 Rest of Asia Pacific Gram-Negative Bacterial Infection Therapeutics Market Size YoY Growth (2015-2026)
1.6.5 Latin America Gram-Negative Bacterial Infection Therapeutics Market Size YoY Growth (2015-2026)
1.6.6 Middle East & Africa Gram-Negative Bacterial Infection Therapeutics Market Size YoY Growth (2015-2026)
2 Gram-Negative Bacterial Infection Therapeutics Market Overview by Type
2.1 Global Gram-Negative Bacterial Infection Therapeutics Market Size by Type: 2015 VS 2020 VS 2026
2.2 Global Gram-Negative Bacterial Infection Therapeutics Historic Market Size by Type (2015-2020)
2.3 Global Gram-Negative Bacterial Infection Therapeutics Forecasted Market Size by Type (2021-2026)
2.4 Enteral Treatment
2.5 Parenteral Treatment
2.6 Topical Treatment
3 Gram-Negative Bacterial Infection Therapeutics Market Overview by Application
3.1 Global Gram-Negative Bacterial Infection Therapeutics Market Size by Application: 2015 VS 2020 VS 2026
3.2 Global Gram-Negative Bacterial Infection Therapeutics Historic Market Size by Application (2015-2020)
3.3 Global Gram-Negative Bacterial Infection Therapeutics Forecasted Market Size by Application (2021-2026)
3.4 Hospitals
3.5 Clinics
3.6 Others
4 Global Gram-Negative Bacterial Infection Therapeutics Competition Analysis by Players
4.1 Global Gram-Negative Bacterial Infection Therapeutics Market Size (Million US$) by Players (2015-2020)
4.2 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Gram-Negative Bacterial Infection Therapeutics as of 2019)
4.3 Date of Key Manufacturers Enter into Gram-Negative Bacterial Infection Therapeutics Market
4.4 Global Top Players Gram-Negative Bacterial Infection Therapeutics Headquarters and Area Served
4.5 Key Players Gram-Negative Bacterial Infection Therapeutics Product Solution and Service
4.6 Competitive Status
4.6.1 Gram-Negative Bacterial Infection Therapeutics Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles and Key Data
5.1 Baxter
5.1.1 Baxter Profile
5.1.2 Baxter Main Business and Company’s Total Revenue
5.1.3 Baxter Products, Services and Solutions
5.1.4 Baxter Revenue (US$ Million) (2015-2020)
5.1.5 Baxter Recent Development and Reaction to Covid-19
5.2 Sanofi
5.2.1 Sanofi Profile
5.2.2 Sanofi Main Business and Company’s Total Revenue
5.2.3 Sanofi Products, Services and Solutions
5.2.4 Sanofi Revenue (US$ Million) (2015-2020)
5.2.5 Sanofi Recent Development and Reaction to Covid-19
5.3 GlaxoSmithKline
5.5.1 GlaxoSmithKline Profile
5.3.2 GlaxoSmithKline Main Business and Company’s Total Revenue
5.3.3 GlaxoSmithKline Products, Services and Solutions
5.3.4 GlaxoSmithKline Revenue (US$ Million) (2015-2020)
5.3.5 Novartis Recent Development and Reaction to Covid-19
5.4 Novartis
5.4.1 Novartis Profile
5.4.2 Novartis Main Business and Company’s Total Revenue
5.4.3 Novartis Products, Services and Solutions
5.4.4 Novartis Revenue (US$ Million) (2015-2020)
5.4.5 Novartis Recent Development and Reaction to Covid-19
5.5 Pfizer
5.5.1 Pfizer Profile
5.5.2 Pfizer Main Business and Company’s Total Revenue
5.5.3 Pfizer Products, Services and Solutions
5.5.4 Pfizer Revenue (US$ Million) (2015-2020)
5.5.5 Pfizer Recent Development and Reaction to Covid-19
5.6 Takeda
5.6.1 Takeda Profile
5.6.2 Takeda Main Business and Company’s Total Revenue
5.6.3 Takeda Products, Services and Solutions
5.6.4 Takeda Revenue (US$ Million) (2015-2020)
5.6.5 Takeda Recent Development and Reaction to Covid-19
5.7 Nektar Therapeutics
5.7.1 Nektar Therapeutics Profile
5.7.2 Nektar Therapeutics Main Business and Company’s Total Revenue
5.7.3 Nektar Therapeutics Products, Services and Solutions
5.7.4 Nektar Therapeutics Revenue (US$ Million) (2015-2020)
5.7.5 Nektar Therapeutics Recent Development and Reaction to Covid-19
5.8 Sumitomo
5.8.1 Sumitomo Profile
5.8.2 Sumitomo Main Business and Company’s Total Revenue
5.8.3 Sumitomo Products, Services and Solutions
5.8.4 Sumitomo Revenue (US$ Million) (2015-2020)
5.8.5 Sumitomo Recent Development and Reaction to Covid-19
5.9 Targeted Genetics
5.9.1 Targeted Genetics Profile
5.9.2 Targeted Genetics Main Business and Company’s Total Revenue
5.9.3 Targeted Genetics Products, Services and Solutions
5.9.4 Targeted Genetics Revenue (US$ Million) (2015-2020)
5.9.5 Targeted Genetics Recent Development and Reaction to Covid-19
6 North America Gram-Negative Bacterial Infection Therapeutics by Players and by Application
6.1 North America Gram-Negative Bacterial Infection Therapeutics Market Size and Market Share by Players (2015-2020)
6.2 North America Gram-Negative Bacterial Infection Therapeutics Market Size by Application (2015-2020)
7 Europe Gram-Negative Bacterial Infection Therapeutics by Players and by Application
7.1 Europe Gram-Negative Bacterial Infection Therapeutics Market Size and Market Share by Players (2015-2020)
7.2 Europe Gram-Negative Bacterial Infection Therapeutics Market Size by Application (2015-2020)
8 China Gram-Negative Bacterial Infection Therapeutics by Players and by Application
8.1 China Gram-Negative Bacterial Infection Therapeutics Market Size and Market Share by Players (2015-2020)
8.2 China Gram-Negative Bacterial Infection Therapeutics Market Size by Application (2015-2020)
9 Rest of Asia Pacific Gram-Negative Bacterial Infection Therapeutics by Players and by Application
9.1 Rest of Asia Pacific Gram-Negative Bacterial Infection Therapeutics Market Size and Market Share by Players (2015-2020)
9.2 Rest of Asia Pacific Gram-Negative Bacterial Infection Therapeutics Market Size by Application (2015-2020)
10 Latin America Gram-Negative Bacterial Infection Therapeutics by Players and by Application
10.1 Latin America Gram-Negative Bacterial Infection Therapeutics Market Size and Market Share by Players (2015-2020)
10.2 Latin America Gram-Negative Bacterial Infection Therapeutics Market Size by Application (2015-2020)
11 Middle East & Africa Gram-Negative Bacterial Infection Therapeutics by Players and by Application
11.1 Middle East & Africa Gram-Negative Bacterial Infection Therapeutics Market Size and Market Share by Players (2015-2020)
11.2 Middle East & Africa Gram-Negative Bacterial Infection Therapeutics Market Size by Application (2015-2020)
12 Gram-Negative Bacterial Infection Therapeutics Market Dynamics
12.1 Covid-19 Impact: Industry Trends
12.2 Covid-19 Impact: Market Drivers
12.3 Covid-19 Impact: Market Challenges
12.4 Porter’s Five Forces Analysis
13 Research Finding /Conclusion
14 Methodology and Data Source
14.1 Methodology/Research Approach
14.1.1 Research Programs/Design
14.1.2 Market Size Estimation
14.1.3 Market Breakdown and Data Triangulation
14.2 Data Source
14.2.1 Secondary Sources
14.2.2 Primary Sources
14.3 Disclaimer
14.4 Author List
List of Figures, Tables and Charts Available in Global Gram-Negative Bacterial Infection Therapeutics Market Report, History and Forecast 2015-2026, Breakdown Data by Companies, Key Regions, Types and Application
List of TablesTable 1. Global Market Gram-Negative Bacterial Infection Therapeutics Market Size (US$ Million) Comparison by Region 2015 VS 2020 VS 2026
Table 2. Global Gram-Negative Bacterial Infection Therapeutics Market Size by Region (2015-2020) (US$ Million)
Table 3. Global Gram-Negative Bacterial Infection Therapeutics Market Size Share by Region (2015-2020)
Table 4. Global Gram-Negative Bacterial Infection Therapeutics Forecasted Market Size by Region (2021-2026) (US$ Million)
Table 5. Global Gram-Negative Bacterial Infection Therapeutics Forecasted Market Size Share by Region (2021-2026)
Table 6. Global Gram-Negative Bacterial Infection Therapeutics Market Size (US$ Million) by Type: 2015 VS 2020 VS 2026
Table 7. Global Gram-Negative Bacterial Infection Therapeutics Market Size by Type (2015-2020) (US$ Million)
Table 8. Global Gram-Negative Bacterial Infection Therapeutics Revenue Market Share by Type (2015-2020)
Table 9. Global Gram-Negative Bacterial Infection Therapeutics Forecasted Market Size by Type (2021-2026) (US$ Million)
Table 10. Global Gram-Negative Bacterial Infection Therapeutics Revenue Market Share by Type (2021-2026)
Table 11. Global Gram-Negative Bacterial Infection Therapeutics Market Size (US$ Million) by Application: 2015 VS 2020 VS 2026
Table 12. Global Gram-Negative Bacterial Infection Therapeutics Market Size by Application (2015-2020) (US$ Million)
Table 13. Global Gram-Negative Bacterial Infection Therapeutics Revenue Market Share by Application (2015-2020)
Table 14. Global Gram-Negative Bacterial Infection Therapeutics Forecasted Market Size by Application (2021-2026) (US$ Million)
Table 15. Global Gram-Negative Bacterial Infection Therapeutics Revenue Market Share by Application (2021-2026)
Table 16. Global Gram-Negative Bacterial Infection Therapeutics Revenue (US$ Million) by Players (2015-2020)
Table 17. Global Gram-Negative Bacterial Infection Therapeutics Revenue Market Share by Players (2015-2020)
Table 18. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Gram-Negative Bacterial Infection Therapeutics as of 2019)
Table 19. Date of Key Manufacturers Enter into Gram-Negative Bacterial Infection Therapeutics Market
Table 20. Global Gram-Negative Bacterial Infection Therapeutics Top Players Headquarters and Area Served
Table 21. Gram-Negative Bacterial Infection Therapeutics Product Solution and Service
Table 22. Global Gram-Negative Bacterial Infection Therapeutics Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Baxter Basic Information List
Table 25. Baxter Description, Business Overview and Total Revenue (US$ Million) Generated in 2019
Table 26. Baxter Gram-Negative Bacterial Infection Therapeutics Products, Services and Solutions
Table 27. Revenue (Million US$) in Gram-Negative Bacterial Infection Therapeutics Business of Baxter (2015-2020)
Table 28. Baxter Recent Developments
Table 29. Sanofi Basic Information List
Table 30. Sanofi Description, Business Overview and Total Revenue (US$ Million) Generated in 2019
Table 31. Sanofi Gram-Negative Bacterial Infection Therapeutics Products, Services and Solutions
Table 32. Revenue (Million US$) in Gram-Negative Bacterial Infection Therapeutics Business of Sanofi (2015-2020)
Table 33. Sanofi Recent Developments
Table 34. GlaxoSmithKline Basic Information List
Table 35. GlaxoSmithKline Description, Business Overview and Total Revenue (US$ Million) Generated in 2019
Table 36. GlaxoSmithKline Gram-Negative Bacterial Infection Therapeutics Products, Services and Solutions
Table 37. Revenue (Million US$) in Gram-Negative Bacterial Infection Therapeutics Business of GlaxoSmithKline (2015-2020)
Table 38. GlaxoSmithKline Recent Developments
Table 39. Novartis Basic Information List
Table 40. Novartis Description, Business Overview and Total Revenue (US$ Million) Generated in 2019
Table 41. Novartis Gram-Negative Bacterial Infection Therapeutics Products, Services and Solutions
Table 42. Revenue (Million US$) in Gram-Negative Bacterial Infection Therapeutics Business of Novartis (2015-2020)
Table 43. Novartis Recent Developments
Table 44. Pfizer Basic Information List
Table 45. Pfizer Description, Business Overview and Total Revenue (US$ Million) Generated in 2019
Table 46. Pfizer Gram-Negative Bacterial Infection Therapeutics Products, Services and Solutions
Table 47. Revenue (Million US$) in Gram-Negative Bacterial Infection Therapeutics Business of Pfizer (2015-2020)
Table 48. Pfizer Recent Developments
Table 49. Takeda Basic Information List
Table 50. Takeda Description, Business Overview and Total Revenue (US$ Million) Generated in 2019
Table 51. Takeda Gram-Negative Bacterial Infection Therapeutics Products, Services and Solutions
Table 52. Revenue (Million US$) in Gram-Negative Bacterial Infection Therapeutics Business of Takeda (2015-2020)
Table 53. Takeda Recent Developments
Table 54. Nektar Therapeutics Basic Information List
Table 55. Nektar Therapeutics Description, Business Overview and Total Revenue (US$ Million) Generated in 2019
Table 56. Nektar Therapeutics Gram-Negative Bacterial Infection Therapeutics Products, Services and Solutions
Table 57. Revenue (Million US$) in Gram-Negative Bacterial Infection Therapeutics Business of Nektar Therapeutics (2015-2020)
Table 58. Nektar Therapeutics Recent Developments
Table 59. Sumitomo Basic Information List
Table 60. Sumitomo Description, Business Overview and Total Revenue (US$ Million) Generated in 2019
Table 61. Sumitomo Gram-Negative Bacterial Infection Therapeutics Products, Services and Solutions
Table 62. Revenue (Million US$) in Gram-Negative Bacterial Infection Therapeutics Business of Sumitomo (2015-2020)
Table 63. Sumitomo Recent Developments
Table 64. Targeted Genetics Basic Information List
Table 65. Targeted Genetics Description, Business Overview and Total Revenue (US$ Million) Generated in 2019
Table 66. Targeted Genetics Gram-Negative Bacterial Infection Therapeutics Products, Services and Solutions
Table 67. Revenue (Million US$) in Gram-Negative Bacterial Infection Therapeutics Business of Targeted Genetics (2015-2020)
Table 68. Targeted Genetics Recent Developments
Table 69. Global Gram-Negative Bacterial Infection Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 70. North America Gram-Negative Bacterial Infection Therapeutics Market Size by Players (2015-2020) (US$ Million)
Table 71. North America Gram-Negative Bacterial Infection Therapeutics Market Size Share by Players (2015-2020)
Table 72. North America Gram-Negative Bacterial Infection Therapeutics Market Size by Application (2015-2020) (US$ Million)
Table 73. Europe Gram-Negative Bacterial Infection Therapeutics Market Size by Players (2015-2020) (US$ Million)
Table 74. Europe Gram-Negative Bacterial Infection Therapeutics Market Size Share by Players (2015-2020)
Table 75. Europe Gram-Negative Bacterial Infection Therapeutics Market Size by Application (2015-2020) (US$ Million)
Table 76. China Gram-Negative Bacterial Infection Therapeutics Market Size by Players (2015-2020) (US$ Million)
Table 77. China Gram-Negative Bacterial Infection Therapeutics Market Size Share by Players (2015-2020) (US$ Million)
Table 78. China Gram-Negative Bacterial Infection Therapeutics Market Size by Application (2015-2020) (US$ Million)
Table 79. Rest of Asia Pacific Gram-Negative Bacterial Infection Therapeutics Market Size by Players (2015-2020) (US$ Million)
Table 80. Rest of Asia Pacific Gram-Negative Bacterial Infection Therapeutics Market Size Share by Players (2015-2020) (US$ Million)
Table 81. Rest of Asia Pacific Gram-Negative Bacterial Infection Therapeutics Market Size by Application (2015-2020) (US$ Million)
Table 82. Latin America Gram-Negative Bacterial Infection Therapeutics Market Size by Players (2015-2020) (US$ Million)
Table 83. Latin America Gram-Negative Bacterial Infection Therapeutics Market Size Share by Players (2015-2020) (US$ Million)
Table 84. Latin America Gram-Negative Bacterial Infection Therapeutics Market Size by Application (2015-2020) (US$ Million)
Table 85. Middle East & Africa Gram-Negative Bacterial Infection Therapeutics Market Size by Players (2015-2020) (US$ Million)
Table 86. Middle East & Africa Gram-Negative Bacterial Infection Therapeutics Market Size Share by Players (2015-2020) (US$ Million)
Table 87. Middle East & Africa Gram-Negative Bacterial Infection Therapeutics Market Size by Application (2015-2020) (US$ Million)
Table 88. Market Top Trends
Table 89. Key Drivers: Impact Analysis (2021-2026)
Table 90. Key Challenges
Table 91. Research Programs/Design for This Report
Table 92. Key Data Information from Secondary Sources
Table 93. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Gram-Negative Bacterial Infection Therapeutics Market Size (US$ Million) Status and Outlook (2015-2026)
Figure 2. Global Gram-Negative Bacterial Infection Therapeutics Market Share by Regions: 2020 VS 2026
Figure 3. North America Gram-Negative Bacterial Infection Therapeutics Market Size (US$ Million) and Growth Rate (2015-2026)
Figure 4. Europe Gram-Negative Bacterial Infection Therapeutics Market Size (US$ Million) and Growth Rate (2015-2026)
Figure 5. China Gram-Negative Bacterial Infection Therapeutics Market Size (US$ Million) and Growth Rate (2015-2026)
Figure 6. Rest of Asia Pacific Gram-Negative Bacterial Infection Therapeutics Market Size (US$ Million) and Growth Rate (2015-2026)
Figure 7. Latin America Gram-Negative Bacterial Infection Therapeutics Market Size (US$ Million) and Growth Rate (2015-2026)
Figure 8. Middle East & Africa Gram-Negative Bacterial Infection Therapeutics Market Size (US$ Million) and Growth Rate (2015-2026)
Figure 9. Global Gram-Negative Bacterial Infection Therapeutics Market Share by Type in 2020 & 2026
Figure 10. Enteral Treatment Market Size (US$ Million) YoY Growth (2015-2026)
Figure 11. Parenteral Treatment Market Size (US$ Million) YoY Growth (2015-2026)
Figure 12. Topical Treatment Market Size (US$ Million) YoY Growth (2015-2026)
Figure 13. Global Gram-Negative Bacterial Infection Therapeutics Market Size Share by Application in 2020 & 2026
Figure 14. Gram-Negative Bacterial Infection Therapeutics Market Size (US$ Million) and Growth Rate in Hospitals (2015-2020)
Figure 15. Gram-Negative Bacterial Infection Therapeutics Market Size (US$ Million) and Growth Rate in Clinics (2015-2020)
Figure 16. Gram-Negative Bacterial Infection Therapeutics Market Size (US$ Million) and Growth Rate in Others (2015-2020)
Figure 17. Gram-Negative Bacterial Infection Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 18. Global Top 5 and Top 10 Players Gram-Negative Bacterial Infection Therapeutics Market Share in 2019
Figure 19. Europe Gram-Negative Bacterial Infection Therapeutics Revenue Market Share by Application (2015-2020)
Figure 20. China Gram-Negative Bacterial Infection Therapeutics Revenue Market Share by Application (2015-2020)
Figure 21. Rest of Asia Pacific Gram-Negative Bacterial Infection Therapeutics Revenue Market Share by Application (2015-2020)
Figure 22. Latin America Gram-Negative Bacterial Infection Therapeutics Revenue Market Share by Application (2015-2020)
Figure 23. Middle East & Africa Gram-Negative Bacterial Infection Therapeutics Revenue Market Share by Application (2015-2020)
Figure 24. Porter's Five Forces Analysis
Figure 25. Bottom-up and Top-down Approaches for This Report
Figure 26. Data Triangulation
Keyplayers in Global Gram-Negative Bacterial Infection Therapeutics Market Report, History and Forecast 2015-2026, Breakdown Data by Companies, Key Regions, Types and Application
BaxterSanofi
GlaxoSmithKline
Novartis
Pfizer
Takeda
Nektar Therapeutics
Sumitomo
Targeted Genetics